The first results from tests show that these dual agonists may lower blood glucose levels and body weight more effectively than GLP-1 agonists on their own, especially when used in higher doses
The people analyzing the data were blinded to treatment/group assignment until breaking the blinding at database lock
While all types of may technically help with both, the three FDA-approved options are intended for different purposes
Instead of 2.4mg once weekly, they inject 1.2mg twice weekly
The few human trials examining cannabinoids for weight management have produced inconsistent results and generally involved small sample sizes with short follow-up periods
Consider evaluation if shedding is patchy, comes with scalp symptoms, is paired with fatigue or other systemic symptoms, or lasts longer than about 6 months without improvement